GNH USA

Europe — EMA

Octagam (Human Normal Immunoglobulin)

GNH USA supplies Octagam (Human Normal Immunoglobulin), a immunoglobulin therapy for primary immunodeficiency and autoimmune disorders.

Human Normal Immunoglobulin

Request sourcing

1
Pack/s

What is Human Normal Immunoglobulin?

Human Normal Immunoglobulin, the active ingredient in Octagam, is an immunoglobulin presented as a solution for intravenous use. It replaces deficient antibodies and is used to treat immune deficiencies and certain autoimmune disorders in both children and adults.

GNH USA supplies Octagam as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres and pharmacies worldwide.

What is Human Normal Immunoglobulin used for?

Octagam is an immunoglobulin therapy that acts on the humoral immune system to provide passive immunity and modulate immune responses. - Primary immunodeficiency diseases: restores protective antibody levels and reduces infection frequency. - Chronic inflammatory demyelinating polyneuropathy (CIDP): improves muscle strength and functional ability. - Multifocal motor neuropathy (MMN): alleviates weakness and enhances motor function. - Immune thrombocytopenia (ITP) refractory to other treatments: increases platelet counts. - Kawasaki disease (in children): reduces coronary artery complications.

What are the side effects of Human Normal Immunoglobulin?

Adverse reactions to Octagam vary with the route of administration and patient characteristics.

Common Side Effects: - Headache - Fever - Chills - Nausea - Fatigue - Mild infusion‑site erythema

Serious or Rare Side Effects: - Anaphylaxis or severe hypersensitivity - Acute renal failure - Thromboembolic events - Hemolytic anemia - Aseptic meningitis - Severe thrombocytopenia

What precautions apply to Human Normal Immunoglobulin?

When using Octagam, clinicians should consider several safety measures to minimise risk. - Assess patient history: identify prior reactions to immunoglobulin products. - Monitor renal function: watch for signs of acute kidney injury. - Observe for thrombotic risk: especially in patients with cardiovascular disease. - Adjust infusion rate: slower rates reduce the likelihood of systemic reactions. - Maintain adequate hydration: helps protect kidney function. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

What does Human Normal Immunoglobulin interact with?

Octagam may interact with other medicines that influence immune function or renal clearance.

Major Interactions (Avoid): - Live vaccines: concurrent use can diminish vaccine efficacy and increase adverse events. - High‑dose aspirin or NSAIDs: may heighten the risk of renal impairment.

Moderate Interactions (Monitor Closely): - Diuretics: can affect fluid balance during infusion. - ACE inhibitors: may potentiate renal side‑effects. - Anticoagulants: monitor coagulation parameters as immunoglobulin can affect platelet function. - Rituximab: combined immunosuppression may increase infection risk. - Corticosteroids: may mask early signs of infusion reactions.

Frequently asked questions

What conditions is Octagam used to treat?+
Octagam is an intravenous immunoglobulin indicated for primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, multifocal motor neuropathy, refractory immune thrombocytopenia, and Kawasaki disease in children. It works by supplying a broad range of antibodies that help restore immune protection and modulate inflammatory processes.
How does Human Normal Immunoglobulin work in the body?+
Human Normal Immunoglobulin supplies pooled IgG antibodies that bind to pathogens, neutralise toxins, and interact with immune‑cell receptors. This restores deficient antibody levels, modulates complement activation and Fc‑receptor signalling, and provides anti‑inflammatory effects that help control autoimmune activity and reduce infection risk.
What is the typical dosing regimen for Octagam?+
The dosing regimen for Octagam is individualized by the prescribing clinician based on the patient’s weight, indication, and clinical response. Doses are usually calculated in grams per kilogram of body weight and administered as an intravenous infusion over several hours.
Is Octagam safe to use during pregnancy or breastfeeding?+
Human normal immunoglobulin is classified as a Category C product; limited data suggest it can be used when the potential benefit outweighs any potential risk to the fetus. It is excreted in small amounts in breast milk, so clinicians weigh maternal benefit against infant exposure before prescribing.
How do I order Octagam from GNH USA?+
To order Octagam, submit an enquiry on the product page at gnh-usa.com specifying the required quantity. GNH USA works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain handling) and any necessary import documentation.
How does Octagam compare with other IVIG products?+
Octagam is a 10 % liquid IVIG formulation comparable to other branded immunoglobulins such as Privigen or Gamunex. Differences may include stabiliser composition, infusion tolerability, and specific manufacturing processes. Clinical efficacy is generally similar, while individual patient tolerance can vary, making product selection a matter of clinician preference and patient response.
What are the recommended storage conditions for Octagam?+
Octagam should be stored refrigerated at 2 °C to 8 °C. The product must be kept in its original container, protected from light, and must never be frozen or shaken. Once removed from refrigeration, it should be used within the time frame specified in the product label.
How is Octagam administered to patients?+
Octagam is given as an intravenous infusion. The infusion rate is started slowly and may be increased as tolerated, typically over 2–4 hours depending on the dose and patient’s reaction. Administration should be performed by trained healthcare professionals in a setting equipped to manage potential infusion reactions.
What are the most serious risks associated with Octagam?+
Serious risks include severe hypersensitivity reactions such as anaphylaxis, acute renal failure, thromboembolic events, hemolytic anemia, aseptic meningitis, and severe thrombocytopenia. Prompt recognition and management of these events are essential, and patients should be monitored closely during and after infusion.
Who should not receive Octagam?+
Octagam is contraindicated in patients with a known severe hypersensitivity to immunoglobulin products or any of its excipients. It should also be avoided in individuals with uncontrolled hyperviscosity, active thrombotic disease, or severe renal impairment unless the benefits clearly outweigh the risks.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Human Normal Immunoglobulin
Route
Intravenous Use
Manufacturer
Jana Pharm D.O.O.
Origin
EU

Related products

Beriglobin

Beriglobin

Human Normal Immunoglobulin

Csl Behring Gmbh
EU
Beriglobin P

Beriglobin P

Human Normal Immunoglobulin

Csl Behring Gmbh
EU
Beriglobina P

Beriglobina P

Human Normal Immunoglobulin

Csl Behring S.A.
EU
Clairyg

Clairyg

Human Normal Immunoglobulin

Lfb Biomedicaments
EU